Cargando…
The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells
Photodynamic treatment (PDT) is often successful when used against aerobic microbes, given their natural susceptibility to oxidative damage. To this end, the current study aimed to explore the photodynamic action of acetylsalicylic acid (ASA; aspirin, which is commonly used to treat non-infectious a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146328/ https://www.ncbi.nlm.nih.gov/pubmed/33922831 http://dx.doi.org/10.3390/ph14050404 |
_version_ | 1783697371442446336 |
---|---|
author | Ogundeji, Adepemi O. Mjokane, Nozethu Folorunso, Olufemi S. Pohl, Carolina H. Nyaga, Martin M. Sebolai, Olihile M. |
author_facet | Ogundeji, Adepemi O. Mjokane, Nozethu Folorunso, Olufemi S. Pohl, Carolina H. Nyaga, Martin M. Sebolai, Olihile M. |
author_sort | Ogundeji, Adepemi O. |
collection | PubMed |
description | Photodynamic treatment (PDT) is often successful when used against aerobic microbes, given their natural susceptibility to oxidative damage. To this end, the current study aimed to explore the photodynamic action of acetylsalicylic acid (ASA; aspirin, which is commonly used to treat non-infectious ailments), when administered to respiring cryptococcal cells. The treatment of cryptococcal cells, i.e., exposure to 0.5 or 1 mM of ASA in the presence of ultraviolet light (UVL) for 10 min, resulted in a significant (p < 0.05) reduction in the growth of tested cells when compared to non-treated (non-Rx) cells, i.e., no ASA and no UVL. The treated cells were also characterised by diseased mitochondria, which is crucial for the survival of respiring cells, as observed by a significant (p < 0.05) loss of mitochondrial membrane potential (ΔΨM) and significant (p < 0.05) accumulation of reactive oxygen species (ROS) when compared to non-Rx cells. Moreover, the photolytic products of acetylsalicylic acid altered the ultrastructural appearance of treated cells as well as limited the expression levels of the capsular-associated gene, CAP64, when compared to non-Rx cells. The results of the study highlight the potential use of ASA as a photosensitiser that is effective for controlling the growth of cryptococcal cells. Potentially, this treatment can also be used as an adjuvant, to complement and support the usage of current anti-microbial agents. |
format | Online Article Text |
id | pubmed-8146328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81463282021-05-26 The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells Ogundeji, Adepemi O. Mjokane, Nozethu Folorunso, Olufemi S. Pohl, Carolina H. Nyaga, Martin M. Sebolai, Olihile M. Pharmaceuticals (Basel) Article Photodynamic treatment (PDT) is often successful when used against aerobic microbes, given their natural susceptibility to oxidative damage. To this end, the current study aimed to explore the photodynamic action of acetylsalicylic acid (ASA; aspirin, which is commonly used to treat non-infectious ailments), when administered to respiring cryptococcal cells. The treatment of cryptococcal cells, i.e., exposure to 0.5 or 1 mM of ASA in the presence of ultraviolet light (UVL) for 10 min, resulted in a significant (p < 0.05) reduction in the growth of tested cells when compared to non-treated (non-Rx) cells, i.e., no ASA and no UVL. The treated cells were also characterised by diseased mitochondria, which is crucial for the survival of respiring cells, as observed by a significant (p < 0.05) loss of mitochondrial membrane potential (ΔΨM) and significant (p < 0.05) accumulation of reactive oxygen species (ROS) when compared to non-Rx cells. Moreover, the photolytic products of acetylsalicylic acid altered the ultrastructural appearance of treated cells as well as limited the expression levels of the capsular-associated gene, CAP64, when compared to non-Rx cells. The results of the study highlight the potential use of ASA as a photosensitiser that is effective for controlling the growth of cryptococcal cells. Potentially, this treatment can also be used as an adjuvant, to complement and support the usage of current anti-microbial agents. MDPI 2021-04-23 /pmc/articles/PMC8146328/ /pubmed/33922831 http://dx.doi.org/10.3390/ph14050404 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ogundeji, Adepemi O. Mjokane, Nozethu Folorunso, Olufemi S. Pohl, Carolina H. Nyaga, Martin M. Sebolai, Olihile M. The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells |
title | The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells |
title_full | The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells |
title_fullStr | The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells |
title_full_unstemmed | The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells |
title_short | The Repurposing of Acetylsalicylic Acid as a Photosensitiser to Inactivate the Growth of Cryptococcal Cells |
title_sort | repurposing of acetylsalicylic acid as a photosensitiser to inactivate the growth of cryptococcal cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146328/ https://www.ncbi.nlm.nih.gov/pubmed/33922831 http://dx.doi.org/10.3390/ph14050404 |
work_keys_str_mv | AT ogundejiadepemio therepurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT mjokanenozethu therepurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT folorunsoolufemis therepurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT pohlcarolinah therepurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT nyagamartinm therepurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT sebolaiolihilem therepurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT ogundejiadepemio repurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT mjokanenozethu repurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT folorunsoolufemis repurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT pohlcarolinah repurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT nyagamartinm repurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells AT sebolaiolihilem repurposingofacetylsalicylicacidasaphotosensitisertoinactivatethegrowthofcryptococcalcells |